Anthropic's Claude Now Competes With ChemDraw on NMR Prediction

Anthropic is working with synthetic, computational, and analytical chemists to improve Claude's performance on NMR spectrum prediction and structure elucidation—tasks central to medicinal chemistry. Evaluations published 5 June 2026 benchmark Claude directly against ChemDraw, the rules-based software standard since the 1980s. Success here would reshape how chemists validate synthetic intermediates and accelerate structure verification cycles in drug discovery pipelines.